Biolase - 32 Year Stock Price History | BIOL
Historical daily share price chart and data for Biolase since 1992 adjusted for splits and dividends. The latest closing stock price for Biolase as of April 23, 2024 is 0.15.
- The all-time high Biolase stock closing price was 242675.52 on January 21, 2004.
- The Biolase 52-week high stock price is 32.09, which is 21293.3% above the current share price.
- The Biolase 52-week low stock price is 0.13, which is 13.3% below the current share price.
- The average Biolase stock price for the last 52 weeks is 4.25.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Biolase Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2024 |
0.4155 |
1.1000 |
1.1300 |
0.1290 |
0.1511 |
-86.53% |
| 2023 |
17.9154 |
71.0100 |
75.0000 |
1.0900 |
1.1220 |
-98.27% |
| 2022 |
501.5730 |
1060.2500 |
1100.2500 |
59.0000 |
65.0000 |
-93.33% |
| 2021 |
1793.8115 |
1175.0000 |
3750.0000 |
952.5000 |
975.0000 |
-6.41% |
| 2020 |
1094.4320 |
1523.5000 |
2175.0000 |
575.0000 |
1041.7500 |
-24.61% |
| 2019 |
3604.8030 |
2600.0000 |
6950.0000 |
1180.2575 |
1381.7500 |
-44.17% |
| 2018 |
4139.2770 |
5250.0000 |
6623.7500 |
2300.0000 |
2475.0000 |
-53.56% |
| 2017 |
12135.2440 |
18375.0000 |
21250.0000 |
4875.0000 |
5330.0000 |
-69.54% |
| 2016 |
16519.5635 |
11155.0000 |
24125.0000 |
9375.0000 |
17500.0000 |
66.45% |
| 2015 |
20443.9583 |
33000.0000 |
34125.0000 |
7751.2500 |
10513.7500 |
-68.02% |
| 2014 |
29947.6399 |
33830.8458 |
41791.0448 |
22000.0000 |
32875.0000 |
-6.60% |
| 2013 |
38242.8873 |
22921.2222 |
72293.2818 |
14777.2351 |
35199.0050 |
56.06% |
| 2012 |
26725.2931 |
32149.0520 |
40514.9763 |
18830.9619 |
22555.4580 |
-26.57% |
| 2011 |
44885.7900 |
18490.8236 |
79226.8631 |
16768.0760 |
30714.8936 |
52.82% |
| 2010 |
17966.3655 |
22166.0183 |
25266.9639 |
7005.8400 |
20098.7213 |
-8.38% |
| 2009 |
17624.1084 |
12288.9324 |
30090.6570 |
3903.7459 |
21936.3187 |
28.19% |
| 2008 |
29956.9223 |
26300.6124 |
48926.0301 |
7224.0547 |
17112.5107 |
-36.86% |
| 2007 |
74710.5046 |
97622.3605 |
116457.7336 |
26415.4623 |
27104.5613 |
-73.03% |
| 2006 |
89430.4878 |
94176.8654 |
126334.8195 |
57424.9179 |
100493.6064 |
9.51% |
| 2005 |
85314.7812 |
119201.6741 |
127800.5950 |
59377.3652 |
91765.0189 |
-26.20% |
| 2004 |
144274.5792 |
218282.5809 |
242675.5169 |
68345.4720 |
124349.5391 |
-34.28% |
| 2003 |
126170.0276 |
62350.1680 |
200614.8002 |
60412.4114 |
189216.2320 |
202.37% |
| 2002 |
58195.8875 |
63034.0821 |
75002.5787 |
41946.7310 |
62578.1394 |
-3.51% |
| 2001 |
43075.6029 |
19947.4943 |
77510.2637 |
17451.2079 |
64857.8530 |
237.09% |
| 2000 |
28950.2373 |
32064.1723 |
74090.6933 |
11740.5252 |
19240.7831 |
-37.20% |
| 1999 |
29188.4764 |
24221.9574 |
40613.0985 |
22443.7808 |
30639.3513 |
26.49% |
| 1998 |
35114.9177 |
34913.8144 |
47019.0938 |
22443.7808 |
24221.9574 |
-35.86% |
| 1997 |
41958.3548 |
47019.0938 |
59842.4830 |
28496.4205 |
37763.4564 |
-17.18% |
| 1996 |
40696.5279 |
41262.8169 |
58417.6620 |
25646.7784 |
45594.2728 |
14.29% |
| 1995 |
21410.0618 |
8548.9261 |
44887.5616 |
5699.2841 |
39894.9887 |
250.00% |
| 1994 |
19825.4482 |
34195.7046 |
36931.3610 |
7836.5156 |
11398.5682 |
-67.95% |
| 1993 |
72071.3896 |
193775.6593 |
193775.6593 |
20061.4800 |
35563.5328 |
-81.65% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
